Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS

BACKGROUND: We explored the effect of teriflunomide on cortical gray matter (CGM) and whole brain (WB) atrophy in patients with clinically isolated syndrome (CIS) from the phase III TOPIC study and assessed the relationship between atrophy and risk of conversion to clinically definite MS (CDMS). MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Neurol Disord
Main Authors: Zivadinov, Robert, Dwyer, Michael G., Carl, Ellen, Poole, Elizabeth M., Cavalier, Steve, Briassouli, Paraskevi, Bergsland, Niels
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672760/
https://ncbi.nlm.nih.gov/pubmed/33240397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420970754
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados